ArticleBMC cancer2023

Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol).

Emilie Thivat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.